Dogs with cancer offered new hope through UQ immunotherapy trials
A clinical research program led by The University of Queensland is inviting dogs with advanced or inoperable cancers to participate in trials evaluating a novel immunomodulatory therapy, offering potential new options for patients with limited treatment pathways. The project will assess the effectiveness of the oral drug Enzistat in dogs with naturally occurring solid tumours, […]
Continue Reading
